TRDX Daily US Market Briefing for May 11th, 2026 – TRDX Daily US Market Briefing

TRDX Daily US Market Briefing – Monday, May 11, 2026

Sector Heatmap

Technology

XLK

~+0.9%

Financials

XLF

~−0.3%

Energy

XLE

~+1.5%

Healthcare

XLV

~+0.7%

Industrials

XLI

~−0.1%

Cons. Disc.

XLY

~+0.2%

Cons. Stap.

XLP

~−0.2%

Materials

XLB

~−0.5%

Real Estate

XLRE

~−0.4%

Utilities

XLU

~−0.3%

Comm. Svcs.

XLC

~+0.3%

Energy +1.5% on WTI +2.4% as Trump rejects Iran deal. Tech leads on AI semi momentum (INTC, QCOM). Healthcare bid on MRNA hantavirus/pipeline catalyst. Real estate/utilities lag on rising 10Y yield (+0.5% to 4.39%). All values ~est.

Market Bias

NEUTRAL

0 Extreme Fear · 100 Extreme Greed

Futures flat-to-slightly negative: S&P –0.02% (7,417.75), Nasdaq +0.08% (29,354.50), Dow –0.06% (49,662). All within ±0.25% neutral band. Last week’s record rally is taking a measured breath. Score: 0 pts.
VIX 18.09 (+5.24%): Fear index bid but remains in the 15–20 “aware but not fearful” band. Iran rejection driving options hedges. Score: 0 pts (neutral band).
Oil geopolitical premium: WTI $97.72 (+2.41%), Brent ~$103.98 (+2.70%). Trump rejected Iran peace proposal; Strait of Hormuz risk active. Inflationary headwind ahead of Tuesday’s CPI. Score: –3 pts.
AI / semi melt-up narrative: MarketWatch: “new top S&P 500 target as melt-up intensifies.” Bloomberg: Alphabet closing in on Nvidia as world’s most valuable co. SOX up 65% YTD. Score: +3 pts.
Preferred sector strength: RKLB +34% earnings blow-out, INTC Apple foundry validation, MRNA triple catalyst — high-beta growth names leading. Stock-picker’s session. Score: +3 pts vs. –3 pts oil = net neutral.

Sources: Reuters newsletter, MarketWatch Need to Know, Bloomberg Morning Briefing Americas, Yahoo Finance Morning Brief (May 11, 2026)

Overall Economic Summary

Monday opens on a split tape. Last week’s record-setting S&P 500 rally is trying to hold its gains as two powerful forces collide: an AI-driven earnings supercycle that continues to deliver jaw-dropping results (RKLB +63.5% revenue growth, Intel’s Apple foundry deal, Qualcomm’s record auto revenues) versus a fresh geopolitical shock from the Middle East. Trump called Iran’s latest peace proposal “totally unacceptable” over the weekend, immediately sending WTI crude surging past $97 and Brent above $104. The oil spike feeds directly into Tuesday’s April CPI print — a release that now carries elevated risk given that gasoline was already up 18.9% in March and the Iran war has pushed the national average within striking distance of all-time highs.

The dominant equity narrative this morning is semiconductor and AI infrastructure validation. Intel’s government-backed foundry partnership with Apple — announced last week — confirmed Intel Foundry Services as a credible domestic TSMC alternative, driving INTC up 190% in 2026 and producing a $30 billion gain on the US government’s 10% stake. Qualcomm’s Q2 beat and record automotive revenues extend the diversification story beyond smartphones into connected vehicles. Bloomberg’s John Authers writes that chip stocks are the “real AI winners” — markets misjudged them — with SOX up 65% YTD. The AI infrastructure buildout is creating AI compute, optical fiber (GLW), satellite (RKLB, ASTS), and stablecoin infrastructure (CRCL) winners simultaneously.

The macro calendar turns serious tomorrow: April CPI at 8:30 AM ET is the week’s most critical print, followed by the Trump–Xi summit in Beijing (May 14–15) — the first US presidential visit to China in nearly a decade. The summit agenda spans a new bilateral “Board of Trade” framework, potential 500-aircraft Boeing purchase commitments, rare earth supply expansion, and agricultural import targets. Whether Trump’s Iran focus displaces progress on the China agenda is a real risk, per CNBC reporting. Traders should right-size positions ahead of Wednesday–Thursday’s summit, which will produce market-moving headlines in real time.

Market Sentiment

Regime call: NEUTRAL. S&P 500 futures at –0.02% (7,417.75), Nasdaq +0.08% (29,354.50), Dow –0.06% (49,662) — all within the ±0.25% neutral band. This is a true stock-picker’s open: no index-level conviction means the tape rewards names with hard catalysts and punishes those without. Per your direction this session: filtering primarily long setups with at least one short in the Top 5 and one short in Secondary Movers. Long-biased by profile default; high-beta growth and AI/semi names take priority over all other sectors.

Key Market Stats

S&P 500 Futures

7,417.75

–0.02%

Nasdaq 100 Futures

29,354.50

+0.08%

Dow Futures

49,662

–0.06%

10Y Yield

4.386%

+0.022 (+0.50%)

VIX

18.09

+5.24%

WTI Crude

$97.72

+2.41%

Brent Crude

~$103.98

~+2.70%

Gold

$4,667.50

–1.34%

DXY

~101.2

~est.

Sources: Reuters/CNBC pre-market data; Benzinga pre-market movers; WebSearch confirmations

Economic Calendar

Time (ET)	Event	Consensus	Prior	Impact
All Day	No Major US Data Releases Today Light Monday — earnings and geopolitics drive the tape. CPI looms tomorrow.	—	—	LOW
Tue 8:30 AM	April CPI (Plan ahead — Tomorrow) Biggest macro event of the week. March came in at +3.3% YoY (gasoline +18.9%). April likely hotter with Iran war oil spike bleeding into energy components. Hot print = bond selloff, tech pressure. Repo positions before release.	~3.7% YoY / +0.6% MoM Core: +2.7% YoY / +0.3% MoM	3.3% YoY	HIGH
May 14–15	Trump–Xi Summit — Beijing First US presidential visit to China in nearly a decade. “Board of Trade” framework, 500 Boeing aircraft deal, rare earths, tariff reductions. Real-time headline risk all week for semi names.	—	—	HIGH
Thu est.	April PPI Producer price inflation follow-through from CPI. Oil pipeline into producer costs.	~est.	—	MED
Fri est.	April Retail Sales + U of Michigan Sentiment Consumer health check. Gasoline prices pressuring discretionary. UMich inflation expectations watched by Fed.	~est.	—	MED

Today’s Earnings

CRCLCircle Internet Group, Inc.Today — Timing TBD

EPS: N/A (first report as public company) · Revenue: ~$250–300M+ est.

Circle’s inaugural quarterly print as a public company. Watch USDC supply growth, transaction volume, and reserve interest income as the three key revenue lines. The CLARITY Act Senate markup expected this week is the bigger catalyst — federal stablecoin framework passage would expand USDC’s institutional addressable market dramatically. Any earnings beat + CLARITY Act progress confirmation creates a powerful dual tailwind for the session.

HIMSHims & Hers Health, Inc.AMC

Consensus EPS: $0.04–$0.13 · Revenue: ~$617–620M est.

HIMS reports after the bell with the GLP-1/weight-loss vertical in focus. The company recently announced Eli Lilly’s Zepbound prescriptions are available through its platform (via LillyDirect) and renewed its Novo Nordisk partnership. The stock is up 30%+ in the past month but still down 21% YTD — any revenue beat above $620M alongside optimistic GLP-1 subscriber commentary should drive a post-earnings leg. Watch ARPU, subscriber count, and full-year guidance revision for the setup into Wednesday.

ASTSAST SpaceMobile, Inc.Q1 Update Call — 5:00 PM ET

EPS est. –$0.21 · Revenue est. $36.91M

AST hosts its Q1 2026 business update call at 5 PM ET. The market demands a direct response to the BlueBird 7 satellite failure and an updated launch cadence confirming or revising the 45-satellite target. FCC deployment approval was secured recently — a material regulatory win. The pre-market bounce of +4.60% signals buy-the-dip positioning into the call. Watch for new commercial carrier agreement announcements and manufacturing throughput updates as the key buy/sell trigger.

Key Events Today

Trump Rejects Iran Peace Offer — Oil Spike Continues All Day

Trump called Iran’s latest proposal “totally unacceptable” over the weekend. WTI immediately jumped 2.4% to $97.72 and Brent pierced $103.98. The Strait of Hormuz disruption risk is driving a full energy risk premium into Monday’s open. This is the primary geopolitical overhang today — energy stocks are the direct beneficiary while defensives and yield-sensitives feel pressure. Watch oil throughout the session for headline escalation signals that could spike VIX above 20.

Hantavirus Cruise Ship Outbreak — First US Case Confirmed Today / All Day

One American passenger from the Hondius cruise ship has tested positive for the Andes strain of hantavirus. 17 US citizens are being flown home; two are in biocontainment units. Three deaths globally in this outbreak. This is the hard catalyst driving MRNA pre-market strength — Moderna is advancing a Phase 1 hantavirus vaccine and Traws Pharma (TRAW) is in clinical development for small-molecule antivirals. The “no approved treatments” angle (30–50% fatality rate) makes any credible mRNA vaccine program immediately commercially relevant.

CLARITY Act Senate Markup Expected This Week Ongoing — Congress Returns

Senate Banking Committee Chairman Tim Scott is expected to schedule a CLARITY Act markup for the week of May 11. The bill creates a federal framework for stablecoin issuance — directly benefiting Circle (CRCL) whose USDC stablecoin would gain bank-partner adoption at scale. The stock surged 16%+ when the Act cleared its prior legislative hurdle on May 4. Any markup confirmation headline is an immediate CRCL catalyst today.

Trump Departs for Beijing — US–China Summit Begins May 14 Today

Trump becomes the first US president to visit China in nearly a decade. Agenda: “Board of Trade” bilateral trade framework, 500 Boeing aircraft purchase commitment, rare earth supply guarantees, agricultural imports, fentanyl precursor cooperation. Watch for Boeing (BA), rare earth miners, and semiconductor supply chain names on any deal headlines throughout the week. CNBC notes that Trump’s Iran focus may delay tariff progress — a real risk to monitor.

Top 5 Movers

INTCLONG Intel Corporation

$124.92

▲ +4.23%

Semiconductors / AI Foundry — Preferred Sector · Pre-mkt Vol: 11,011K (avg ~8,100K, 2.94× RVOL) · ATR: $6.74 · Beta: 2.33 · Cap: $627.8B

Catalyst

Intel’s national-security-backed comeback is in full acceleration. The US government acquired a 10% INTC stake at $20.47/share (August 2025) — Trump stated last week the position has returned over $30 billion in 90 days. The May 8 anchor catalyst was a preliminary Apple–Intel foundry deal (Apple agreed to manufacture silicon at Intel fabs), confirming Intel Foundry Services as a tier-1 domestic manufacturer. INTC is up 190% YTD in 2026. AI-driven revenue surged 40% YoY with six consecutive quarterly beats. Today’s 11.01M pre-market shares is the single largest absolute volume figure across the entire screener — institutional accumulation, not retail noise.

Why It’s Moving

The Apple deal validation created a step-change re-rating of Intel’s foundry business from “hope” to “reality.” With TSMC increasingly geopolitically constrained and US reshoring policy providing structural tailwinds, INTC is absorbing every dollar seeking domestic semiconductor exposure. The 11M pre-market volume — and growing as the open approaches — confirms institutional size entering today’s session. This is continuation momentum from last week’s ATH catalyst, not a gap-and-fade setup. #1 conviction name by raw volume and catalyst quality.

Key Daily Price Levels

Pre-market: $124.92. Opening range: $122.00–$128.00. VWAP anchor from Friday: ~$119–121 area. ATR(14): $6.74 — full daily range expected. Bias: LONG — buy dips toward opening range low; first target $130, extended $135. 50-day MA ~$102 (well below, supportive).

Support & Resistance

Support: $120.00 (May 8 Apple deal breakout base), $115.50 (prior consolidation). Resistance: $130.00 (psychological / near ATH extension), $135.00 (price target projection).

Wyckoff Phase E — Sustained markup through successive higher lows on expanding institutional volume. Government endorsement + Apple catalyst = structural demand.

Sources: The Hill (Trump $30B Intel claim); Fox Business; Intel Newsroom (Apple-Intel foundry, May 8); Yahoo Finance (INTC +190% 2026 report); Benzinga

HIMSLONG Hims & Hers Health, Inc.

$28.27

▲ +3.86%

DTC Health / GLP-1 Platform — Acceptable Sector · Pre-mkt Vol: 1,022K (avg ~804K, 4.80× RVOL) · ATR: $2.05 · Beta: 1.67 · Cap: $6.4B

Catalyst

HIMS reports Q1 2026 earnings after the close today — the primary catalyst driving pre-market positioning. Two secondary catalysts are amplifying the setup: (1) the company recently integrated Eli Lilly’s Zepbound, KwikPen, and Foundayo prescriptions through LillyDirect on its platform, directly expanding the GLP-1 weight-loss offering, and (2) a renewed Novo Nordisk partnership provides a second branded GLP-1 channel. Analysts expect Q1 revenue of ~$617–620M — a beat above $620M with strong GLP-1 subscriber commentary would set up a meaningful post-close move. Stock is up 30%+ in the past month but still down 21% YTD, leaving room for a re-rating on a clean print.

Why It’s Moving

The GLP-1 weight-loss market is one of the highest-growth verticals in healthcare — Lilly and Novo have billion-dollar drugs that HIMS now helps distribute, creating a recurring revenue flywheel. Institutional investors are front-running the earnings print on the belief that GLP-1 subscriber growth and ARPU expansion will beat the conservative consensus. The 4.80× RVOL on over 1 million pre-market shares is the clearest signal that this is institutional conviction, not thin speculation. Watch for any pre-earnings news wire or guidance pre-announcement before the open.

Key Daily Price Levels

Pre-market: $28.27. Opening range: $27.50–$29.00. VWAP anchor: ~$27.00 area. ATR(14): $2.05. Bias: LONG — hold above $27.50 for first target $30.00, extended $32.00 on a strong earnings beat. Be aware this is a pre-earnings long — position size accordingly and consider reducing before the AMC print to avoid binary risk.

Support & Resistance

Support: $26.50 (pre-run base), $25.00 (psychological / prior week low). Resistance: $30.00 (round number / analyst PT cluster), $32.00 (extended earnings-beat target).

Wyckoff Phase D — Markup phase building into a hard catalyst event. Pre-earnings accumulation on expanding relative volume.

Sources: Hims & Hers Q1 2026 earnings preview (GuruFocus, MSN); TipRanks analyst expectations; StockStory “Everything You Need To Know Ahead Of Earnings” (May 10, 2026); MarketBeat earnings date

QCOMLONG QUALCOMM Incorporated

$219.09

▲ +5.15%

Semiconductors / Auto Chips — Preferred Sector · Pre-mkt Vol: 634.5K (avg ~458K, 4.30× RVOL) · ATR: $11.96 · Beta: 1.62 · Cap: $230.9B

Catalyst

Qualcomm’s Q2 FY2026 earnings (reported April 29) continue to drive post-earnings follow-through. Revenue of $10.6B with non-GAAP EPS of $2.65 — at the high end of guidance. The standout metric: automotive revenues exceeded $5 billion annualized run rate for the first time ever, powered by the Snapdragon Digital Chassis platform. IoT revenues +9% YoY. Q3 guidance $9.2B–$10.0B with EPS $2.10–$2.30, ahead of prior consensus. Today’s gap extends on broad semiconductor sector strength and the ongoing AI compute buildout narrative.

Why It’s Moving

QCOM is benefiting from the same institutional semiconductor rotation lifting INTC and the broader SOX. The automotive chip story is structural and multi-year — $5B annualized auto revenue is a record, validating diversification away from smartphone-only dependence. The 4.30× relative volume on 634K shares (growing from 493K at early check) means momentum is building into the open. A name gapping +5%+ on moderate but rising volume often has cleaner intraday follow-through than names already exhausted in pre-market.

Key Daily Price Levels

Pre-market: $219.09. Opening range: $216.00–$223.00. VWAP anchor: ~$207 (prior Friday close). ATR(14): $11.96. Bias: LONG — hold above $215 opening range low; first target $225, extended $232. 50-day MA ~$190 (well below, supportive).

Support & Resistance

Support: $212.00 (pre-earnings base), $207.00 (prior Friday close / gap fill). Resistance: $225.00 (round number / psychological), $232.00 (extended target).

Wyckoff Phase D/E — Post-earnings momentum carrying price through resistance levels on above-average volume. Clean trend continuation structure.

Sources: Qualcomm Q2 FY2026 Earnings Transcript (The Motley Fool, Apr 29, 2026); Investing.com earnings call transcript; Yahoo Finance Q2 highlights

ASTSLONG AST SpaceMobile, Inc.

$75.05

▲ +3.53%

Space Tech / Satellite Broadband — Preferred Sector · Pre-mkt Vol: 717.0K (avg ~480K, 2.68× RVOL) · ATR: $7.01 · Beta: 0.69 · Cap: $29.1B

Catalyst

ASTS hosts its Q1 2026 business update call at 5:00 PM ET today — the session’s cleanest binary event for the space sector. The market is positioning ahead of the call expecting management to address the BlueBird 7 satellite failure directly and restore execution credibility. A significant positive: FCC deployment approval for the satellite constellation was recently secured, a material regulatory milestone. The stock has bounced +14.8% in the past 24 hours — today’s pre-market gap of +3.53% on 717K shares (2.68× RVOL) reflects institutional accumulation ahead of the update, not just retail momentum.

Why It’s Moving

ASTS is the purest play on direct-to-device satellite broadband — a $1T+ global addressable market if the technology executes. The FCC approval removes a key regulatory overhang. The market sold the BlueBird 7 setback hard; the 5 PM call is the moment management either restores the execution narrative or extends the pain. Institutional buyers front-running positive call outcomes are driving today’s pre-market volume. Watch for new commercial carrier agreements (AT&T, Verizon, Rakuten) and revised satellite launch cadence as the key buy catalysts on the call.

Key Daily Price Levels

Pre-market: $75.05. Opening range: $73.00–$77.00. VWAP anchor: ~$72 area. ATR(14): $7.01 — wide daily range expected. Bias: LONG intraday — hold above $72 VWAP for first target $80, extended $85. Note: position sizing matters here — hold through the 5 PM call only if you have high conviction on the execution update; otherwise consider trimming into strength before close.

Support & Resistance

Support: $72.00 (VWAP / prior consolidation), $68.43 (prior week’s close before bounce). Resistance: $80.00 (round number / pre-BlueBird-selloff level), $85.00 (extended target).

Wyckoff Phase C/D — Re-accumulation after shakeout from BlueBird 7 news. Smart money repositioning ahead of the execution confirmation call.

Sources: BusinessWire (ASTS Q1 call announcement, Apr 28); Benzinga “BlueBird Fallout” analysis; ForeignPolicyJournal ASTS stock close $68.43 (May 6); AST SpaceMobile FCC approval news

PLTRSHORT Palantir Technologies Inc.

$137.80

▼ –2.29%

AI / Data Platforms — Preferred Sector Pullback · Pre-mkt Vol: 505.1K (avg ~440K, 6.58× RVOL) · ATR: $6.57 · Beta: 1.46 · Cap: $330.4B

Catalyst

No negative fundamental catalyst — PLTR is pulling back on a flat-to-negative tape after a significant recent run. The –2.29% gap (exceeding our –2.0% minimum threshold) on 6.58× RVOL is the tell: this is not index drift but active selling by participants exiting last week’s strength. On a neutral Monday following a record-setting week, the highest-beta AI names are the first to see profit-taking, and PLTR’s massive YTD run makes it a natural target for trim orders. The high relative volume (6.58×) confirms institutional participation in the selldown, not just retail jitters.

Why It’s Moving

PLTR has been one of the strongest AI data platform names in 2026. That strength is precisely why it’s a tactical short today: winners get sold first on risk-off mornings. The combination of slightly negative futures, rising VIX (+5.24%), and oil-driven inflation uncertainty creates a “reduce high-beta” impulse for portfolio managers. PLTR at –2.29% on 505K pre-market shares is orderly distribution — not a panic, not a blowup. That makes it a cleaner short than a name gapping –8% on a specific bad catalyst, because the price action is more predictable: fade the dead-cat, target the gap fill.

Key Daily Price Levels

Pre-market: $137.80. Opening range: $136.50–$139.50. VWAP (prior Friday): ~$141.00 (now overhead resistance). ATR(14): $6.57. Bias: SHORT — this is a tactical session short only, NOT a structural thesis. Best entry: fade the dead-cat bounce toward $139.50–$141.00 (VWAP region). First target: $134.00. Stop: above $141.50 (full VWAP reclaim = short thesis broken). If PLTR reclaims VWAP with volume, cover — the name is a preferred sector long on strength.

Support & Resistance

For short entries — Resistance (entry / stop zones): $139.50 (opening range high), $141.00 (prior Friday VWAP), $141.50 (hard stop). Downside targets: $134.00 (first target / ATR pullback level), $130.00 (extended if index weakness accelerates).

Not a Wyckoff distribution event — this is intraday profit-taking on a healthy trend. Short the session, respect the structure.

Sources: TradingView PLTR screener data (May 11, 2026); pre-market scanner — confirmed –2.29% on 505K shares, 6.58× RVOL

Research Themes

🔧 AI Semiconductor Supply Chain Renaissance — Markets Still Underestimating the Winners

Bloomberg’s John Authers writes directly: “it’s impossible to argue against chip stocks’ earnings strength.” SOX is up 65% YTD — yet Bloomberg argues markets STILL underestimate the compounding effect of AI infrastructure buildout on semiconductor earnings. Intel’s Apple foundry deal confirmed domestic fab viability. QCOM’s $5B automotive milestone proves chip demand is diversifying into every connected device. Alphabet is closing in on Nvidia as the world’s most valuable company. This theme has years of runway and is generating alpha every session. The Trump-Xi summit this week could add rare earth supply chain guarantees as a structural tailwind for US fab buildout.

Core: INTC, QCOM, NVDA, AMD, MU, MRVL · Infrastructure: ANET, CRWV, GLW, VRT · Space/Semi adjacent: RKLB, ASTS

💲 Stablecoin Regulatory Inflection — CLARITY Act This Week

The CLARITY Act is the most important piece of US crypto legislation in a decade. Senate Banking markup expected the week of May 11. If passed, a federal framework enabling banks to issue stablecoins dramatically expands USDC’s addressable market — directly benefiting Circle. CRCL surged 16%+ on the prior legislative milestone (May 4). Earnings today are the setup; CLARITY Act markup confirmation is the catalyst that takes this from a trading move to a re-rating event. Watch for any senate schedule confirmation as an immediate intraday CRCL catalyst.

Core: CRCL · Adjacent: MSTR, CORZ, COIN, HOOD

🧬 Biotech Catalyst Cluster — mRNA Beyond COVID / Hantavirus Urgency

Moderna is proving the mRNA platform is genuinely disease-agnostic. The NEJM-published flu vaccine data (26.6% relative efficacy improvement vs. standard-dose) creates a hard binary FDA decision on August 5. The active hantavirus cruise ship outbreak — US case confirmed today per Reuters — transforms MRNA’s Phase 1 hantavirus data from academic to urgent. With 30–50% fatality rate and zero approved treatments, first-mover mRNA vaccine credibility carries real commercial premium. The re-rating thesis: market is still anchored to the COVID-era MRNA identity. The August 5 FDA catalyst is the next major unlock in ~85 days.

Core: MRNA · Adjacent: TRAW (hantavirus small-molecule), BNTX (mRNA platform comp)

Secondary Movers

Ticker	Company	Price	Gap %	Pre-mkt Vol	Note
RKLB LONG	Rocket Lab USA	~est.	+34.0%	~500K+	A+ setup per TRDX prototype: Q1 earnings blow-out after prior-day red. Revenue beat, record launch cadence, Neutron update boosting multi-year bull thesis. ≥5% gap, multi-catalyst (earnings + defense/space sector rotation + Neutron optionality), Beta ~1.5+. Watch VWAP as anchor — continuation above = add. Preferred sector: space/disruptors. ATR elevated.
MNDY LONG	monday.com Ltd.	$72.07	+24.97%	366K (8.58×)	Q1 earnings catalyst — massive gap on strong revenue growth and raised guidance. 8.58× 5-min RVOL is the highest conviction signal on the scanner. High-growth SaaS with AI workflow automation narrative; market rewarding execution in a sector where peers are getting punished for deceleration. Watch for open-drive continuation above prior close. ATR $4.45.
MRNA LONG	Moderna, Inc.	$54.35	+6.27%	702K (6.99×)	Triple catalyst day: Q1 earnings beat + flu vaccine Phase 3 data readout + hantavirus mRNA program update. 6.99× RVOL confirms broad institutional participation. Biotech with strong near-term newsflow — stock was deeply oversold from post-COVID selloff; catalyst stack gives structural bulls a re-entry. Watch $55 resistance; break = gap fill target $60+. ATR $3.36.
IREN SHORT	IREN Limited	$61.20	–9.00%	4,226K (3.10×)	Q3 revenue miss — NVIDIA-hype AI data center story colliding with weak fundamentals. –9% gap on highest absolute volume on the scanner (4.2M+ pre-market). 3.10× RVOL with sustained selling = no bounce buyers. Crypto-miner / AI infrastructure hybrid with high beta (3.15) = volatile downside on earnings disappointment. Fade dead-cat rallies below VWAP. Tactical session short. ATR $4.58.
GLW LONG	Corning Inc.	$186.94	+3.12%	288K (4.51×)	AI data center fiber optic cable demand — Corning is the picks-and-shovels play on hyperscaler interconnect buildout. 4.51× RVOL confirms institutional interest. Indirect AI infrastructure with lower volatility than direct semi plays. Q1 data center segment revenue accelerating — hyperscalers pulling forward fiber orders. Watch $190 as near-term resistance. ATR $11.33.

The Days Ahead

Date	Event / Description
Mon May 11	CRCL Q1 · HIMS Q1 AMC · ASTS 5PM Call · Iran oil spike · CLARITY Act markup watch Multi-event Monday. Stock-picker’s session on neutral futures. Trump departs for Beijing. No major US economic data — all eyes on tonight’s earnings and CLARITY Act headlines.
Tue May 12	🔴 April CPI — 8:30 AM ET (MAJOR EVENT) Consensus: +3.7% YoY, +0.6% MoM; Core +2.7% / +0.3%. Iran war oil spike risks upside surprise. Hot print = bond selloff + tech rotation. Reduce position size into the release. Biggest risk event of the week.
Wed May 13	April PPI · Trump Arrives Beijing · US-China Talks Begin PPI follows CPI — energy pipeline costs in focus. Summit opening session expected to cover Boeing aircraft deal and “Board of Trade” framework. Watch BA, rare earth miners, semi supply chain names for intraday headline volatility.
Thu May 14	Trump-Xi Summit Day 1 · Initial Jobless Claims · POET Earnings AMC “Board of Trade” framework expected to be formally announced. POET Technologies (AI photonic chips) reports Q1 after close. Watch for joint statement headlines on tariffs and rare earths — real-time market movers for semi names.
Fri May 15	Summit Concludes · Retail Sales · U of Michigan Sentiment Summit joint statement expected. Retail Sales reflects consumer health under oil inflation pressure. UMich inflation expectations closely watched by the Fed. Right-size into weekend with Iran/Hormuz geopolitical risk still active.
Week of May 18	FOMC Minutes (Wed est.) · Alibaba Earnings · Cisco Earnings FOMC minutes parsed for rate path language. Alibaba and Cisco provide global cloud infrastructure demand read-throughs. MRNA FDA flu vaccine countdown continues (Aug 5 decision — 85+ days out, accelerating relevance each week).